General Information
Revision date
2019-10-17
Product name
Capecitabine
Substance name
Capecitabine
CAS No.
154361-50-9
supplier name
Scafell Organics
Emergency telephone
+44 (0) 7590 545705
Icons in SDS
Company Information
company name
Molekula Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@molekula.com, kbowen@molekula.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H350, H360Df
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
CLP CLASSIFICATION
Germ cell mutagenicity, Category 2 H341 Carcinogenicity, Category 1B H350 Reproductive toxicity, Category 1B H360Df
Hazard statements
see section 16 : H341 - Suspected of causing genetic defects. H350 - May cause cancer. H360Df - May damage the unborn child. Suspected of damaging fertility.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS08
Signal word
Danger
Precautionary statements
P201 - Obtain special instructions before use. P263 - Avoid contact during pregnancy and while nursing. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
